Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VolitionRx Limited
VNRX | US
0.20
USD0.00
0.66%
VNRX | US
About VolitionRx Limited
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
06/03/2026
Close
0.20
Open
0.20
High
0.21
Low
0.20
VolitionRx Limited a multi-national epigenetics company engages in the development of blood tests to help diagnose and monitor a range of cancers and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover a solution to profiling nucleosomes. The company is based in Henderson Nevada.
View LessVNRX | US
Risk
108.5
Sharpe
-0.75
Luna's Score
45/100
Recommendation
Sell
Luna says (VNRX | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
142.5%1 month
108.5%3 months
104.2%6 months
94.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
38.44
Debt to equity
-0.27
Debt to assets
0.45
Ent. to EBITDA
-1.43
Ent. to rev.
68.97
PEG
-
Other Fundamentals
EBITDA
-31.64M
MarketCap
18.25M
MarketCap(USD)
18.25M
Div. yield
-
Op. margin
-1.77K
Erngs. growth
-
Rev. growth
83.00
Ret. on equity
-730.06
Short ratio
4.25
Short perc.
0.59
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.09
Range1M
0.11
Range3M
0.22
Volumes: Market Activity
Rel. volume
1.65
Price X volume
677.19K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.43 | 12.67 | Cheaper |
| Ent. to Revenue | 68.97 | 44.00 | Expensive |
| PE Ratio | - | 40.09 | - |
| Price to Book | 38.44 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 104.15 | 59.59 | Riskier |
| Debt to Equity | -0.27 | -14.36 | Expensive |
| Debt to Assets | 0.45 | 0.34 | Expensive |
| Market Cap | 18.25M | 13.71B | Emerging |
